Published in
Taylor & Francis, Expert Opinion on Drug Safety, 1(14), p. 31-44
DOI: 10.1517/14740338.2015.976610
Links
Tools
Safety considerations when using anti-TNFα therapy to treat Crohn’s disease
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 